Search research articles
Contact Us
Filters
Showing results (881-890 of 4,265) with videos related to
Page
of 427
Sort By:
Cancer Discovery
|
April 14, 2018
Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound <i>ALK</i> Mutations in ALK-Positive Lung Cancer
Satoshi Yoda, Jessica J Lin, Michael S Lawrence, et al.
Cancer Discovery
|
May 17, 2018
9/11 Firefighters at Risk for Multiple Myeloma
Cancer Discovery
|
May 18, 2018
Little Benefit to Breakthrough Cancer Drugs
Cancer Discovery
|
May 19, 2018
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma
Ferdinandos Skoulidis, Michael E Goldberg, Danielle M Greenawalt, et al.
Cancer Discovery
|
May 6, 2018
Q&A: Ned Sharpless on His Vision for NCI
Cancer Discovery
|
August 18, 2018
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Spencer C Wei, Colm R Duffy, James P Allison
Cancer Discovery
|
June 13, 2019
Merck Buys Maker of HIF2α Inhibitor
Cancer Discovery
|
June 14, 2019
AMG 510 First to Inhibit "Undruggable" KRAS
Cancer Discovery
|
October 17, 2012
Compensatory pathways in oncogenic kinase signaling and resistance to targeted therapies: six degrees of separation
Livio Trusolino, Andrea Bertotti
Cancer Discovery
|
October 17, 2012
Setting the stage for cancer startups
Page
of 427
Search research articles
Search
Showing results (881-890 of 4,265) with videos related to
Sort By:
Page
of 427
Cancer Discovery
|
April 14, 2018
Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound <i>ALK</i> Mutations in ALK-Positive Lung Cancer
Satoshi Yoda, Jessica J Lin, Michael S Lawrence, et al.
Cancer Discovery
|
May 17, 2018
9/11 Firefighters at Risk for Multiple Myeloma
Cancer Discovery
|
May 18, 2018
Little Benefit to Breakthrough Cancer Drugs
Cancer Discovery
|
May 19, 2018
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma
Ferdinandos Skoulidis, Michael E Goldberg, Danielle M Greenawalt, et al.
Cancer Discovery
|
May 6, 2018
Q&A: Ned Sharpless on His Vision for NCI
Cancer Discovery
|
August 18, 2018
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Spencer C Wei, Colm R Duffy, James P Allison
Cancer Discovery
|
June 13, 2019
Merck Buys Maker of HIF2α Inhibitor
Cancer Discovery
|
June 14, 2019
AMG 510 First to Inhibit "Undruggable" KRAS
Cancer Discovery
|
October 17, 2012
Compensatory pathways in oncogenic kinase signaling and resistance to targeted therapies: six degrees of separation
Livio Trusolino, Andrea Bertotti
Cancer Discovery
|
October 17, 2012
Setting the stage for cancer startups
Page
of 427